Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs. [electronic resource]
Producer: 19990917Description: 444-52 p. digitalISSN:- 0171-5216
- Animals
- Antineoplastic Agents, Hormonal -- therapeutic use
- Apoptosis -- drug effects
- Bombesin -- analogs & derivatives
- Cricetinae
- Disease Models, Animal
- Down-Regulation -- drug effects
- ErbB Receptors -- drug effects
- Estradiol -- blood
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Gonadotropin-Releasing Hormone -- analogs & derivatives
- Growth Hormone -- blood
- Luteinizing Hormone -- blood
- Mesocricetus
- Mitotic Index -- drug effects
- Nucleolus Organizer Region -- drug effects
- Pancreatic Neoplasms -- blood
- Peptide Fragments -- therapeutic use
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.